Wednesday 5 September 2012

Informations of Cefpodoxime Dry Syrup Focal D3 Injection


Welcome To Plenus Pharmaceuticals (P) Ltd
Plenus Pharmaceuticals is built on its meaning of completeness in pharmaceutical field through our quality healthcare service that leads to healthy life everywhere. It is complete healthcare in every aspect where there is no compromise with quality of products, ensuring full satisfaction to concerned entities.

Cefpodoxime Dry Syrup Focal D3 Injection should be used with caution ad cross-allergenicity between the penicillin and Cefpodoxime can occur. Cefpodoxime use may result in overgrowth of non-susceptible organisms. Cefpodoxime can lead to colitis so always consider the diagnosis in patients who develop diarrhoea. Cefpodoxime Dry Syrup Focal D3 Injection is well tolerated by paediatric patients, with adverse events that are consistent with those reported for other oral cephalosporins. Cefpodoxime Dry Syrup Focal D3 Injection 8 to 10 mg/kg/day for 5 to 10 days was at least as effective as standard 10-day regimens of penicillin V in the treatment of children with pharyngitis and/or tonsillitis. Significant differences in favour of cefpodoxime proxetil were demonstrated in terms of clinical and bacteriological criteria. The clinical efficacy of 5 days of treatment with cefpodoxime proxetil is similar to that of 10 days of treatment with penicillin V.

Cefpodoxime Dry Syrup Focal D3 Injection proxetil also demonstrated clinical efficacy in pediatric patients with skin and soft tissue infections. Cefpodoxime proxetil showed efficacy similar to that of cefuroxime axetil or cefaclor. It is generally well tolerated and demonstrates good bacteriological and clinical efficacy in paediatric patients with various infectious diseases, including acute otitis media, tonsillitis and/or pharyngitis.


Keywords


Contact Us-

Plenus Pharmaceuticals Private Limited
PLENUS BUILDING
SHIV VIHAR, NEAR LAL MANDIR,
ARYA NAGAR JWALAPUR, HARIDWAR. (U.K.) 249407
Mobile: 09737475726